Screen Readers Skip to Content
Tweet Facebook Email
Print Page

Canavan Disease Information

Published 2009-04-01 15:47:00 - (11 years ago). Last updated 2019-08-12 00:32:27 - (7 months ago).

Author: Disabled World - Contact : www.disabled-world.com

Outline: Canavan disease is a severe progressive inherited genetic disorder of the central nervous system. Canavan disease is caused by mutations in the gene for an enzyme called aspartoacylase. Although Canavan disease may occur in any ethnic group, it is more frequent among Ashkenazi Jews from eastern Poland, Lithuania, and western Russia, and among Saudi Arabians.

Main Digest

Canavan disease alternate names include: Aminoacylase-2 (ACY2) Deficiency, Aspartoacylase (ASPA) Deficiency, Canavan's Leukodystrophy, Spongy Degeneration of the Central Nervous System or Neuroaxis, Van Bogaert-Bertrand Syndrome.

Canavan disease (CD) is a severe progressive inherited (genetic) disorder of the central nervous system (CNS). It is one of the most common cerebral degenerative diseases of infancy, is a gene-linked, neurological birth disorder in which the white matter of the brain degenerates into spongy tissue riddled with microscopic fluid-filled spaces.

Canavan disease is one of a group of genetic disorders known as the leukodystrophies. These diseases cause imperfect growth or development of the myelin sheath, the fatty covering that acts as an insulator around nerve fibers in the brain. Myelin, which lends its color to the "white matter" of the brain, is a complex substance made up of at least ten different chemicals. Each of the leukodystrophies affects one (and only one) of these substances.

Canavan disease is caused by mutations in the gene for an enzyme called aspartoacylase.

Symptoms of Canavan disease, which appear in early infancy and progress rapidly, may include mental retardation, loss of previously acquired motor skills, feeding difficulties, abnormal muscle tone (floppiness or stiffness), and an abnormally large, poorly controlled head. Paralysis, blindness, or hearing loss may also occur.

Children are characteristically quiet and apathetic.

Although Canavan disease may occur in any ethnic group, it is more frequent among Ashkenazi Jews from eastern Poland, Lithuania, and western Russia, and among Saudi Arabians.

Clinical findings leading up to the diagnosis would include:

The test to confirm diagnosis is a full gene sequence analysis of ASPA. Gross deletion/duplication analysis of the entire ASPA gene is performed to detect known and potential novel gross deletions.

Canavan disease causes brain tissue atrophy cystic cavities resulting in enlargement of the brain and head size. There is no cure, nor is there a standard course of treatment. Treatment is symptomatic and supportive. The prognosis for Canavan disease is poor. Death usually occurs before age 4.

Similar Documents

For further related information see our full list of Neurological Disorders Documents.

If you use an RSS feed reader you are welcome to subscribe to our latest Neurological Disorders publications.

Important Disclaimer:
Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.

Please report 📧 outdated or inaccurate information to us.